Ammonia detection: A pathway towards potential point-of-care diagnostics

Biosens Bioelectron. 2024 May 1:251:116100. doi: 10.1016/j.bios.2024.116100. Epub 2024 Feb 2.

Abstract

Invasive methods such as blood collection and biopsy are commonly used for testing liver and kidney function, which are painful, time-consuming, require trained personnel, and may not be easily accessible to people for their routine checkup. Early diagnosis of liver and kidney diseases can prevent severe symptoms and ensure better management of these patients. Emerging approaches such as breath and sweat analysis have shown potential as non-invasive methods for disease diagnosis. Among the many markers, ammonia is often used as a biomarker for the monitoring of liver and kidney functions. In this review we provide an insight into the production and expulsion of ammonia gas in the human body, the different diseases that could potentially use ammonia as biomarker and analytical devices such as chemiresistive gas sensors for non-invasive monitoring of this gas. The review also provides an understanding into the different materials, doping agents and substrates used to develop such multifunctional sensors. Finally, the current challenges and the possible future trends have been discussed.

Keywords: Ammonia gas detection; Breath analysis; Chemiresistive gas sensors; Noninvasive diagnostics; Point-of-care diagnostics; Wearable sensors.

Publication types

  • Review

MeSH terms

  • Ammonia*
  • Biomarkers
  • Biosensing Techniques* / methods
  • Humans
  • Point-of-Care Testing

Substances

  • Ammonia
  • Biomarkers